The hormonal upheaval in the run-up to menopause can cause cognitive difficulties. But researchers are also finding that this can be a critical window for protecting long-term brain health ...

Numerous hospitals that receive federal funding are reportedly continuing to offer body-mutilating sex change procedures to ...

A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according ...

March is Endometriosis Awareness Month. It's a painful disease that affects women. So what causes it, and who is at risk for the disease?

COVID infections, even if mild or asymptomatic, may be causing long-term cellular and organ damage, as well as increasing ...

Scientists and physicians discuss the clinical ramifications of the Trump administration’s anti-LGBTQ+ initiatives.

Dr. Frita McRae Fisher reveals the deep-rooted systemic failures in Black healthcare, exposing hidden disparities and ...

Exercise, be it walking, spinning or swimming, makes us happy because it gives us a sense of achievement. "Dopamine, our reward chemical kicks in very quickly when we exercise, which is a nice way of ...

When it comes to antibiotic stewardship and clinical care, Brad Spellberg, MD, just wants to see the data.

Eli Lilly has launched its much-anticipated diabetes and weight-loss drug, Mounjaro (tirzepatide), in India, offering a new ...